Search Results - David Cutter

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    P077: Predicting radiotherapy dose to the heart and the risk of radiation-related cardiac toxicity for Hodgkin lymphoma patients, using pre-chemotherapy PET-CT scans by Rebecca Shakir, Victoria Butterworth, Georgios Ntentas, Johanna Ramroth, David Cutter

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  2. 2

    P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in Engl... by David Jones, Rebecca Shakir, Paolo Candio, Johanna Ramroth, Jane Wolstenholme, Alastair Gray, David Cutter, Georgios Ntentas

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  3. 3

    T022: Sharing decisions regarding radiotherapy for Hodgkin lymphoma: a qualitative study of the experiences of patients and clinicians in the UK by Rebecca Shakir, Catriona Gilmour-Hamilton, Craig Bakin, Isabelle Gent, Adam Holloway, Alison Meeson, Johanna Ramroth, Georgios Ntentas, David Cutter, Michele Peters

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  4. 4

    Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma by Ashley Way, MD, Savas Ozdemir, MD, Barbara Berges, RN, Nataliya Getman, MS, Xiaoying Liang, PhD, Nancy P. Mendenhall, MD, Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, David Cutter, MRCP, FRCR, DPhil, Raymond B. Mailhot Vega, MD, MPH

    Published in International Journal of Particle Therapy (2021-10-01)
    Get full text
    Article


  5. 5

    P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma by Yvonne M.G. Geurts, Rebecca Shakir, Georgios Ntentas, Sander Roberti, Marianne Aznar, Katinka John, Johanna Ramroth, Cécile P.M. Janus, Augustinus Krol, Judith Roesink, Richard W.M. Van Der Maazen, Josée. M. Zijlstra, Sarah Darby, Berthe M. P. Aleman, Flora E. Van Leeuwen, David Cutter, Michael Schaapveld

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  6. 6

    P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untre... by John Radford, Toyin Adedayo, Arzhang Ardavan, Sally F. Barrington, Leanne Berkahn, Stephane Chauvie, Laura Clifton-Hadley, Graham P. Collins, Michael Crump, David Cutter, Darren Edwards, Martin Hutchings, Tim Illidge, Amy A. Kirkwood, Kim Linton, Craig H. Moskowitz, Pip Patrick, Beth Phillips, Lois Shepherd, Sanne Tonino, Judith Trotman, Joanna Williams, Nicole Wong Doo

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


Search Tools: